INTANGIBLE ASSETS (Details Narrative) - USD ($) |
1 Months Ended | 3 Months Ended | 9 Months Ended | |||
|---|---|---|---|---|---|---|
Oct. 12, 2018 |
Sep. 30, 2026 |
Sep. 30, 2025 |
Sep. 30, 2026 |
Sep. 30, 2025 |
Dec. 31, 2025 |
|
| Accumulated amortization | $ 53,055 | $ 53,055 | $ 36,440 | |||
| Customer [Member] | ||||||
| Amortization expense | 8,474 | $ 68,294 | 25,146 | $ 156,631 | ||
| Intangible assets acquired fair value | 336,200 | 336,200 | ||||
| Accumulated amortization | 53,055 | $ 53,055 | ||||
| Estimated useful lives | 10 years | |||||
| Intellectual Property [Member] | ||||||
| Amortization expense | 0 | 295 | $ 295 | 884 | ||
| Impairment | 0 | 6,374 | ||||
| Naltrexone Implant Formulation [Member] | Australia from Trinity Compound Solutions [Member] | ||||||
| Patent acquired purchase price | $ 15,200 | |||||
| Estimated useful lives | 13 years | |||||
| Trademarks [Member] | ||||||
| Intangible assets acquired fair value | 249,500 | 249,500 | ||||
| Impairment | $ 0 | $ 0 | $ 0 | $ 0 | ||
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of residual value of finite-lived asset acquired in business combination, asset acquisition, and from joint venture formation. Excludes financial asset. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Total loss recognized during the period from the impairment of goodwill plus the loss recognized in the period resulting from the impairment of the carrying amount of intangible assets, other than goodwill. No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|